Dinesh Talwar, MD
Neurology with Special Qualifications in Child Neurology · Tucson, AZNPI 1831168566
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 28.9% of the total. Reporting peaked in 2022 at $14,164 and has fallen 81.4% since, to $2,634 in 2024. Among neurology with special qualifications in child neurology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $147.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$9K
- Immedica Pharma US, Inc.$8K
- UCB, Inc.$5K
- Sunovion Pharmaceuticals Inc.$3K
- Eisai Inc.$2K
- Zogenix Inc.$1K
- plus $2K from 19 others
Across 90 payments — averaging $5552.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$409K
- Takeda Pharmaceuticals U.S.A., Inc.$56K
- Zogenix Inc.$26K
- Eisai Inc.$10K
What the payments were for
- Consulting fees$9,77933%
- Speaking & faculty fees$11,62839%
- Travel & lodging$4,19514%
- Food & beverage$4,05514%
- Education$440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 17 | $8,569 |
| Immedica Pharma US, Inc. | 12 | $8,292 |
| UCB, Inc. | 25 | $5,221 |
| Sunovion Pharmaceuticals Inc. | 18 | $3,262 |
| Eisai Inc. | 27 | $1,575 |
| Zogenix Inc. | 2 | $1,016 |
| Supernus Pharmaceuticals, Inc. | 48 | $496 |
| SK Life Science, Inc. | 8 | $325 |
| Neurelis, Inc. | 6 | $163 |
| PTC Therapeutics, Inc. | 1 | $121 |
| AstraZeneca(2 entities) | 2 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $89 |
| Mallinckrodt Enterprises LLC | 5 | $87 |
| Amneal Pharmaceuticals LLC | 6 | $83 |
| Greenwich Biosciences, Inc. | 5 | $72 |
| AbbVie | 2 | $47 |
| Cranial Technologies, Inc | 3 | $40 |
| Acadia Pharmaceuticals Inc | 2 | $32 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Biomarin Pharmaceutical Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Livanova USA, Inc. | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Sumitomo Pharma America, Inc. | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,701 in reported general payments places this provider in the 95th percentile of 49 neurology with special qualifications in child neurology providers in Arizona.
See all neurology with special qualifications in child neurology providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology with special qualifications in child neurology in Tucson
- Chi DaiTucson$6K
- Young LeeTucson$3K
- Nadia FikeTucson$431
- Padmavati EksambeTucson$384
- John GrayTucson$370
- Freddie JosephTucson$337
- Angus WilfongPhoenix$348K
- Clara ChowPhoenix$35K
- Saunder BernesPhoenix$27K
- Randa JarrarPhoenix$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.